Ticker Symbol | Entity Name | As Of Date | Company Name | Followers | Employees on Linkedin | Link | Industry | Date Added | Date Updated | Description | Website | Specialities | Logo | HQ.Street | HQ.City | HQ.State | HQ.Country | HQ.Postal | Headcount change in past 24 months | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
private:microbiotix-2 | 154375 | May 29th, 2019 12:00AM | Microbiotix, Inc | 327 | 30.00 | Open | Pharmaceuticals | May 29th, 2019 07:51PM | May 29th, 2019 07:51PM | Microbiotix is a privately-held, clinical stage biopharmaceutical company engaged in the discovery and development of novel small molecule anti-infective drugs. The Company’s clinical programs are focused on hepatitis C virus (HCV) and cytomegalovirus (CMV). | Open | Antimicrobial research and development | Open | US | Microbiotix | Pharmaceuticals & Biotechnology | ||||||
private:microbiotix-2 | 154375 | Nov 7th, 2017 12:00AM | Microbiotix, Inc | 229 | 23.00 | Open | Pharmaceuticals | Nov 7th, 2017 06:47PM | Nov 7th, 2017 06:47PM | Microbiotix is a privately-held, clinical stage biopharmaceutical company engaged in the discovery and development of novel small molecule anti-infective drugs. The Company’s clinical programs are focused on hepatitis C virus (HCV) and cytomegalovirus (CMV). | Microbiotix | Pharmaceuticals & Biotechnology | ||||||||||
private:microbiotix-2 | 154375 | Nov 1st, 2017 12:00AM | Microbiotix, Inc | 226 | 23.00 | Open | Pharmaceuticals | Nov 1st, 2017 06:19AM | Nov 1st, 2017 06:19AM | Microbiotix is a privately-held, clinical stage biopharmaceutical company engaged in the discovery and development of novel small molecule anti-infective drugs. The Company’s clinical programs are focused on hepatitis C virus (HCV) and cytomegalovirus (CMV). | Microbiotix | Pharmaceuticals & Biotechnology |